PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'University Hospitals, Cleveland Medical Center, Cleveland, OH, United States of America; Case Western Reserve University, Cleveland, OH, United States of America. Electronic address: yazan.abou-ismail@hsc.utah.edu.\', \'University Hospitals, Cleveland Medical Center, Cleveland, OH, United States of America; Case Western Reserve University, Cleveland, OH, United States of America.\', \'Alaska Native Medical Center, Anchorage, AK, United States of America.\', \'University Hospitals, Cleveland Medical Center, Cleveland, OH, United States of America; Case Western Reserve University, Cleveland, OH, United States of America. Electronic address: lxn64@case.edu.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0049-3848(20)30271-110.1016/j.thromres.2020.06.029
?:doi
?:hasPublicationType
?:journal
  • Thrombosis research
is ?:pmid of
?:pmid
?:pmid
  • 32788101
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.096
?:rankingScore_hIndex
  • 99
is ?:relation_isRelatedTo_publication of
?:title
  • The hypercoagulable state in COVID-19: Incidence, pathophysiology, and management.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all